ALTO NEUROSCIENCE INC (ANRO:NYSE)
$22.62 0.91 (4.1916%)
Analysed ALTO NEUROSCIENCE INC (ANRO:NYSE) News Sources
Here's Why You Should Add ANRO Stock to Your Portfolio Now
14-10-2026
yahoo.com
Top 1% Alto Neuroscience Plummets On Its Shocking Schizophrenia Miss
02-04-2026
yahoo.com
Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia
15-06-2026
yahoo.com
Is Alto Neuroscience, Inc. (ANRO) Stock Positioned for Growth With New Insights Into Anhedonia Treatment?
02-07-2026
yahoo.com
Alto Neuroscience Announces Pricing of $100.0 Million Underwritten Registered Direct Offering of Common Stock
13-07-2026
yahoo.com
Alto Neuroscience (ANRO) Stock Looks Stretched On Expanded ALTO 207 Plans
16-08-2026
yahoo.com
Are Alto Neuroscience’s (ANRO) Rising Losses Funding a Stronger Depression Pipeline or Diluting Discipline?
16-08-2026
yahoo.com
Alto Neuroscience (ANRO) Reports Another Quarterly Loss, Is The Stock Already Overvalued?
16-08-2026
yahoo.com
Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer
27-08-2026
yahoo.com
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
09-09-2026
yahoo.com
What is the current price of ALTO NEUROSCIENCE INC (ANRO:NYSE)?
The current price of ALTO NEUROSCIENCE INC (ANRO:NYSE) is $22.62.
ALTO NEUROSCIENCE INC (ANRO:NYSE) absolute price change since previous trading day?
The absolute price change of ALTO NEUROSCIENCE INC (ANRO:NYSE) since the previous trading day is $0.91.
ALTO NEUROSCIENCE INC (ANRO:NYSE) percentage price change since previous trading day?
The percentage price change of ALTO NEUROSCIENCE INC (ANRO:NYSE) since the previous trading day is 4.1916%.
What is the most recent average sentiment score for ALTO NEUROSCIENCE INC (ANRO:NYSE)?
The most recent average sentiment score for ALTO NEUROSCIENCE INC (ANRO:NYSE) is 82 out of 100.
What is the most recent average sentiment for ALTO NEUROSCIENCE INC (ANRO:NYSE)?
The most recent sentiment for ALTO NEUROSCIENCE INC (ANRO:NYSE) is .
SEC-8K** Filing Available For ALTO NEUROSCIENCE INC (ANRO:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.